Impact of Low-Burden <i>TP53</i> Mutations in the Management of CLL.

Lazarian, Gregory; Cymbalista, Florence; Baran-Marszak, Fanny

Impact of Low-Burden TP53 Mutations in the Management of CLL.

Lazarian, Gregory; Cymbalista, Florence; Baran-Marszak, Fanny.

Afiliação

Lazarian G; Service d'Hématologie Biologique, Hôpital Avicenne, Assistance Publique des Hôpitaux de Paris, Paris, France.
Cymbalista F; Service d'Hématologie Biologique, Hôpital Avicenne, Assistance Publique des Hôpitaux de Paris, Paris, France.
Baran-Marszak F; Service d'Hématologie Biologique, Hôpital Avicenne, Assistance Publique des Hôpitaux de Paris, Paris, France.

Front Oncol ; 12: 841630, 2022.

Article em En | MEDLINE | ID: mdl-35211418

Palavras-chave

CLL (Chronic Lymphocytic Leukemia); NGS (next-generation sequencing); TP53; clinical impact; minor clone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google